3
项与 Bone marrow-derived mesenchymal stromal cells(The University of Queensland) 相关的临床试验Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells for the Treatment of Refractory Proctitis in Ulcerative Colitis - BMMSCproctitis
Phase 2 Randomised Controlled Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (CLAD)
This study is designed for lung transplant patients who have developed chronic lung allograft dysfunction (CLAD). Consented patients will receive 4 intravenous doses of allogeneic, bone-marrow-derived MSCs (2*10^6 cells/kg/dose) or matching placebo over a period of 2 weeks with a 12 month follow up.
/ Unknown status临床1/2期IIT Phase I/II Randomized Clinical Trial to Assess the Safety and Feasibility of Transendocardial Injection of Bone Marrow Autologous Mesenchymal Stem Cells in Patients With Idiopathic Dilated Cardiomyopathy.
The purpose of this study is to assess the safety, the feasibility and the efficacy of transendocardial injection of bone marrow-derived mesenchymal stem cells (MSCs) in patients with dilated idiopathic cardiomyopathy.
100 项与 Bone marrow-derived mesenchymal stromal cells(The University of Queensland) 相关的临床结果
100 项与 Bone marrow-derived mesenchymal stromal cells(The University of Queensland) 相关的转化医学
100 项与 Bone marrow-derived mesenchymal stromal cells(The University of Queensland) 相关的专利(医药)
100 项与 Bone marrow-derived mesenchymal stromal cells(The University of Queensland) 相关的药物交易